AT368886B - Verfahren zur herstellung einer fuer die intravenoese anwendung bestimmten immunglobulinloesung - Google Patents
Verfahren zur herstellung einer fuer die intravenoese anwendung bestimmten immunglobulinloesungInfo
- Publication number
- AT368886B AT368886B AT0505279A AT505279A AT368886B AT 368886 B AT368886 B AT 368886B AT 0505279 A AT0505279 A AT 0505279A AT 505279 A AT505279 A AT 505279A AT 368886 B AT368886 B AT 368886B
- Authority
- AT
- Austria
- Prior art keywords
- immunglobulin
- producing
- intravenous application
- solution intended
- intended
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
- Y10S530/831—Cohn fractions
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19782837168 DE2837168A1 (de) | 1978-08-25 | 1978-08-25 | Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten immunglobulinloesung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA505279A ATA505279A (de) | 1982-04-15 |
| AT368886B true AT368886B (de) | 1982-11-25 |
Family
ID=6047909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0505279A AT368886B (de) | 1978-08-25 | 1979-07-23 | Verfahren zur herstellung einer fuer die intravenoese anwendung bestimmten immunglobulinloesung |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4322403A (de) |
| JP (1) | JPS5547627A (de) |
| AT (1) | AT368886B (de) |
| DE (1) | DE2837168A1 (de) |
| FR (1) | FR2433946A1 (de) |
| GB (1) | GB2032437B (de) |
| SE (1) | SE7906272L (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE19735T1 (de) * | 1982-02-08 | 1986-05-15 | Schweiz Serum & Impfinst | Intravenoes verabreichbares humanes immunglobulin und verfahren zu dessen herstellung. |
| US4465670A (en) * | 1982-07-23 | 1984-08-14 | Dainippon Pharmaceutical Co., Ltd. | Method for the treatment of systemic lupus erythematosus and primary glomerulonephritis and agent therefor |
| DE3310150A1 (de) * | 1983-03-21 | 1984-09-27 | Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München | Verfahren zur herstellung einer nebenwirkungsfreien igg-immunglobulinloesung fuer die intravenoese applikation |
| US4725673A (en) * | 1986-08-29 | 1988-02-16 | Alpha Therapeutic Corporation | Plasma fraction purification using silica resin bound to a ligand |
| DE3640513A1 (de) * | 1986-11-27 | 1988-06-09 | Biotest Pharma Gmbh | Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates |
| US5219578A (en) * | 1991-02-25 | 1993-06-15 | Innovet, Inc. | Composition and method for immunostimulation in mammals |
| EP0973384A4 (de) * | 1997-02-13 | 2004-10-13 | Sky High Llc | Organkonservierungslösung |
| US6962700B1 (en) | 2000-09-13 | 2005-11-08 | Atopix Pharmaceuticals Corporation | Method of manufacturing immune globulin |
| ES2776657T3 (es) | 2005-06-14 | 2020-07-31 | Amgen Inc | Formulaciones de proteínas autotamponantes |
| US7879332B2 (en) * | 2005-09-01 | 2011-02-01 | Plasma Technologies, Llc | Ultra-high yield intravenous immune globulin preparation |
| US8293242B2 (en) * | 2005-09-01 | 2012-10-23 | Plasma Technologies, Llc | Ultra-high yield of alpha-1-anti-trypsin |
| US20070049732A1 (en) * | 2005-09-01 | 2007-03-01 | Zurlo Eugene J | Ultra-high yield intravenous immune globulin preparation |
| US20100278935A1 (en) * | 2007-07-30 | 2010-11-04 | Stacey William C | Immune System Modulator Formulation |
| EP3528787B1 (de) | 2016-10-21 | 2026-01-07 | Amgen Inc. | Pharmazeutische formulierungen und verfahren zur herstellung davon |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL6702923A (de) * | 1966-04-06 | 1967-10-09 | ||
| US3449316A (en) * | 1967-03-03 | 1969-06-10 | American Cyanamid Co | Process for the purification of gamma globulin employing bentonite |
| DE1792555C3 (de) * | 1968-09-19 | 1980-01-10 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | Verfahren zur Herstellung einer für die intravenöse Anwendung geeigneten Gammaglobulinlösung |
| IL34079A (en) * | 1969-04-01 | 1973-02-28 | Upjohn Co | Purification of ypsilon-globulins |
| US3607857A (en) * | 1970-03-03 | 1971-09-21 | Upjohn Co | Process of removing acrinol from gamma globulin using siliceous material such as silica gel |
| FR2267115B1 (de) * | 1974-04-12 | 1977-11-10 | Merieux Inst | |
| DE2604759C2 (de) * | 1976-02-07 | 1983-06-01 | SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld | Verfahren zur Gewinnung von iv-verträglichen Γglobulinen |
| US4136094A (en) * | 1977-08-31 | 1979-01-23 | The Regents Of The University Of Minnesota | Preparation of intravenous human and animal gamma globulins and isolation of albumin |
-
1978
- 1978-08-25 DE DE19782837168 patent/DE2837168A1/de not_active Withdrawn
-
1979
- 1979-07-23 SE SE7906272A patent/SE7906272L/xx not_active Application Discontinuation
- 1979-07-23 AT AT0505279A patent/AT368886B/de not_active IP Right Cessation
- 1979-08-21 GB GB7929104A patent/GB2032437B/en not_active Expired
- 1979-08-24 FR FR7921345A patent/FR2433946A1/fr active Pending
- 1979-08-24 JP JP10731579A patent/JPS5547627A/ja active Pending
-
1980
- 1980-09-22 US US06/189,001 patent/US4322403A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| FR2433946A1 (fr) | 1980-03-21 |
| ATA505279A (de) | 1982-04-15 |
| SE7906272L (sv) | 1980-02-26 |
| DE2837168A1 (de) | 1980-03-06 |
| GB2032437B (en) | 1982-10-27 |
| JPS5547627A (en) | 1980-04-04 |
| US4322403A (en) | 1982-03-30 |
| GB2032437A (en) | 1980-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATA323879A (de) | Verfahren zur herstellung thixotropiemitteln fuer ueberzugsmittel | |
| AT385201B (de) | Verfahren zur herstellung einer antiinflammatorischen ophthalmischen loesung | |
| ATA38983A (de) | Verfahren zur herstellung einer insulinloesung | |
| AT360148B (de) | Verfahren zur herstellung einer stabilen injektionsloesung | |
| AT370445B (de) | Verfahren zur herstellung einer ausscheidungsge- haerteten legierung auf kupferbasis | |
| AT374770B (de) | Verfahren zur herstellung einer aluminium-modefizierten kieselsaeure | |
| AT368886B (de) | Verfahren zur herstellung einer fuer die intravenoese anwendung bestimmten immunglobulinloesung | |
| ATA148982A (de) | Verfahren zur herstellung einer analgetisch wirkenden zusammensetzung | |
| AT357248B (de) | Verfahren zur herstellung einer selektivbe- schichtung | |
| AT361632B (de) | Verfahren zur herstellung einer waessrigen instillationszubereitung | |
| ATA55880A (de) | Verfahren zur herstellung einer katalysatorzusammensetzung | |
| AT368885B (de) | Verfahren zur herstellung einer fuer die intravenoese anwendung bestimmten gammaglobulinloesung | |
| AT370115B (de) | Verfahren zur herstellung einer waesserigen kunststoffdispersion | |
| AT363177B (de) | Verfahren zur herstellung einer stabilen thymosinfraktion 5 | |
| AT368528B (de) | Verfahren zur herstellung einer katalytischen titankomponente | |
| AT358015B (de) | Verfahren zur herstellung einer 2-arylpropion- saeure | |
| AT370116B (de) | Verfahren zur herstellung einer waesserigen kunststoffdispersion | |
| AT373626B (de) | Verfahren zur herstellung von briketts fuer die kontrollierte zugabe von aktiven elementen | |
| AT368390B (de) | Verfahren zur herstellung einer heterovakzine | |
| LU81217A1 (de) | Verfahren zur herstellung von ziehsteinbohrungen | |
| DD138506A1 (de) | Verfahren zur herstellung einer waessrigen loesung | |
| AT376879B (de) | Verfahren zur herstellung einer injektionsloesung | |
| ATA328780A (de) | Verfahren zur herstellung acylaminobenzoesaeurecerivaten | |
| ATA282779A (de) | Verfahren zur herstellung einer hetero- klischen verbindung | |
| ATA741577A (de) | Verfahren zur herstellung thermoplastischer terpolymerisate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |